Novel IKK inhibitors: beta-carbolines (Q44489612)

3 December 2017

Novel IKK inhibitors: beta-carbolines (English)

1 reference

3 December 2017

Alfredo C Castro

1

1 reference

3 December 2017

Luan C Dang

2

1 reference

3 December 2017

François Soucy

3

1 reference

3 December 2017

Louis Grenier

4

1 reference

3 December 2017

Hormoz Mazdiyasni

5

1 reference

3 December 2017

Maria Hottelet

6

1 reference

3 December 2017

Lana Parent

7

1 reference

3 December 2017

Christine Pien

8

1 reference

3 December 2017

Vito Palombella

9

1 reference

3 December 2017

Julian Adams

10

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

3 December 2017

1 reference

3 December 2017

13

1 reference

3 December 2017

2419-2422

1 reference

3 December 2017

14

1 reference

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

IkappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

Sulindac inhibits activation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

NF-kappa B as a therapeutic target in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900408-6

7 January 2021

10.1016/S0960-894X(03)00408-6

Identifiers

DOI

1 reference

3 December 2017

1 reference